Elite Pharmaceuticals ELTP
OTC ELTP
$0.25 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Elite Pharmaceuticals (ELTP) Depreciation & Amortization - Total (2014 - 2026)

Updated

Elite Pharmaceuticals (ELTP) reported Depreciation & Amortization - Total of $252,975 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 8.1% from $275,413 a year earlier.

Analysis

Elite Pharmaceuticals (ELTP) Depreciation & Amortization - Total (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Elite Pharmaceuticals' Depreciation & Amortization - Total came in at $1.13 million, up 2.3% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $1.07 million, down 12.6% from FY2025.

  • Depreciation & Amortization - Total has a five-year compound annual growth rate of -3.8% (FY2021 to FY2026).
  • By fiscal year, Depreciation & Amortization - Total came in at $1.23 million in FY2025 (-7.1%), $1.32 million in FY2024 (+6.7%), $1.24 million in FY2023 (+3.6%) and $1.19 million in FY2022 (-8.1%).
  • The fiscal Q1 2027 figure ranks as the lowest quarterly Depreciation & Amortization - Total since fiscal Q2 2025.
  • The high point for year-over-year Depreciation & Amortization - Total in five years was fiscal Q2 2022 (growth of 15.8%); the low point was fiscal Q3 2022 (a decline of 42.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Elite Pharmaceuticals 269.28 Mn 150.96 Mn 13.51 Mn 252,975.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 252,975.00
Jun 30, 2025 275,413.00
Mar 31, 2025 290,392.00
Dec 31, 2024 313,060.00
Sep 30, 2024 227,356.00
Jun 30, 2024 322,103.00
Mar 31, 2024 328,382.00
Dec 31, 2023 336,614.00
Sep 30, 2023 327,240.00
Jun 30, 2023 328,282.00
Mar 31, 2023 314,405.00
Dec 31, 2022 314,610.00
Sep 30, 2022 316,007.00
Jun 30, 2022 292,748.00
Mar 31, 2022 297,277.00
Dec 31, 2021 293,014.00
Sep 30, 2021 295,491.00
Jun 30, 2021 309,157.00
Mar 31, 2021 319,441.00
Dec 31, 2020 505,987.00
API Access

Elite Pharmaceuticals Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=ELTP&period=max&api_key=YOUR_API_KEY